Antibiotic Outbreak, Risk Factors for Never Event, Prediction of Inappropriate Use
NCT03489330 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2021-03-16
Summary
In order to decrease inappropriate antibiotic use, drivers of inappropriate use must be identified locally. This study will focus on the MOST inappropriate use, which are defined as 'never events'. Previous work has shown that antibiotic use clusters over time. It is hypothesized that never events also cluster over time. Using electronic data capture strategies, an algorithm will be developed to quickly and accurately identify areas of antibiotic use concern. Secondly, a framework will be developed, utilizing antimicrobial consumption data and captured signals of inappropriate antimicrobial use to provide targets for antimicrobial stewardship efforts.
Conditions
Sponsors & Collaborators
-
Northwestern Memorial Hospital
collaborator OTHER - collaborator OTHER
-
Henry Ford Hospital
collaborator OTHER -
Wayne State University
collaborator OTHER -
Midwestern University
lead OTHER
Principal Investigators
-
Marc H Scheetz, PharmD, MSc · Midwestern University
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-01-01
- Primary Completion
- 2017-10-01
- Completion
- 2020-12-29
Countries
- United States
Study Locations
More Related Trials
-
Impact of Pharmaceutical Interviews Regarding the Management of Adverse Effects Related to the Antibiotic Therapy Used to Treat Osteoarticular Infections During Return Home
NCT05248490 ·Status: COMPLETED ·Phase: NA
-
Study Comparing Nitrofurantoin to Fosfomycin for Acute Urinary Tract Infection in Women
NCT01966653 ·Status: UNKNOWN ·Phase: PHASE4
-
Population Pharmacokinetic-pharmacodynamic (PK-PD) Study of 9 Broad-Spectrum Anti-infective Agents in the Cerebro Spinal Fluid (CSF) of Brain Injured Patients With an External Ventricular Drainage (EVD).
NCT03481569 ·Status: COMPLETED ·Phase: PHASE1
-
DetectAB - Detecting Antibiotics
NCT03678142 ·Status: COMPLETED
-
A Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Subjects
NCT02439359 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Performance and Reproducibility of the Accelerate PhenoTest™ Blood Culture (BC) Kit With New Antibiotic Wave I Updates
NCT04295915 ·Status: COMPLETED
-
Promoting Optimal Treatment Choices in Neonates With Suspected Early-Onset Sepsis
NCT06845332 ·Status: RECRUITING
-
PREdiction of CEphalosporinase Producing Enterobacteria During Ventilator-associated Pneumonia for Therapeutic Stewardship
NCT05486130 ·Status: UNKNOWN
-
Effect of Antibiotic Choice On ReNal Outcomes (ACORN)
NCT05094154 ·Status: COMPLETED ·Phase: PHASE4
-
Discontinuation of Antibiotic Susceptibility Testing on Enterococcus Faecalis Positive Urine Cultures in Hospitalized Patients: an Impact on Antibiotic Prescriptions? (FaecaCible)
NCT05743192 ·Status: COMPLETED
-
Clinical Usefulness of Mic/Breakpoint Ratio and Penetration in Tissues. A Prospective Study of Clinical Validation
NCT01551719 ·Status: WITHDRAWN ·Phase: NA
-
Selective Reporting of Antibiotic Susceptibility Test Results in Urinary Tract Infections in the Outpatient Setting
NCT03612297 ·Status: UNKNOWN
-
Impact of New CLSI Guidelines on Antibiotic Susceptability Pattern
NCT01352377 ·Status: UNKNOWN
-
Nebulized Ceftazidime and Amikacin in Ventilator Associated Pneumonia
NCT00786305 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics and Pharmacodynamics and Selected Antibiotics During Pregnancy
NCT00214331 ·Status: COMPLETED
-
Study of Adverse Effects Occuring in Patients Receiving an Antibiotic Treatment With Temocillin
NCT03599999 ·Status: COMPLETED
-
Pharmacokinetic and Pharmacodynamic Evaluation of Linezolid Administered Intravenously in MRSA-positive, Morbidly Obese Patients With Pneumonia
NCT01805284 ·Status: COMPLETED ·Phase: PHASE4
-
Beta-lactams Therapeutic Drug Monitoring in Critically Ill Patients
NCT05352997 ·Status: COMPLETED
-
Evaluation of the Impact of the Modification of Antibiotic Susceptibility Testing on Antibiotic Prescriptions
NCT05902299 ·Status: UNKNOWN
-
The Effect of Oral Antibiotics on Synovial Fluid and Differential for the Diagnosis of Infection
NCT03551847 ·Status: WITHDRAWN ·Phase: NA
-
Trial of Antimicrobial Restraint in Presumed Pneumonia
NCT04438187 ·Status: COMPLETED ·Phase: NA
-
Oral Amoxicillin and Cephalexin PK/PD in Neonates
NCT04916951 ·Status: COMPLETED ·Phase: PHASE1
-
Antibiotic Adherence Practices in Dermatologic Surgery
NCT04117724 ·Status: COMPLETED
-
Immunosuppression and Intensive Care Unit-acquired Multidrug-resistant Bacteria
NCT06652126 ·Status: RECRUITING
-
Pharmacokinetics and Toxicodynamics of Daptomycin in Bone and Joint Infections
NCT04933344 ·Status: UNKNOWN